https://www.selleckchem.com/products/cc-122.html
Decreased CDKN1A expression at mRNA (p = 0.02) and protein levels (p = 0.02) were associated with short overall survival and were independent predictors of prognosis (p less then 0.01 and less then 0.05 respectively). CDKN1A expression status is a prognostic biomarker independent of tumor stage. CDKN1A immunohistochemistry may be used to identify chRCC patients at greater risk of disease progression.Background Physical exercise helps to maintain a healthy lifestyle and its practice is recommended for women during pregnancy as a means of
Like
Comment
Share
